Advent prepares sale of TCP ports company and purchase of pharmaceuticals

After announcing two acquisitions in less than two months-the chemical distributor quantiQ, which belonged to Braskem, and State College, Cesuca American Investment Fund Advent is about to close other deals in the country. Named as favourite to buy German generic drugs maker, which has the American giant Pfizer as a partner, Advent should also conclude soon the sale of TCP port terminal of Paranaguá (PR), a company valued at about $3 billion, according to sources heard by the '' State ''.
The Manager is also in advanced talks to open the capital of Biotoscana, which in Brazil pharmaceutical controls United Medical. In addition, evaluates the Via retail, Electronics Division of the French group Casino. In the latter case, there is still no ongoing negotiations. The network was put up for sale by the French retailer, which hired Banco Santander to advise transaction.
Despite having attracted the attention of investors, as the Chilean Falabella network, Lojas Americanas and the Advent of sale Via retail, owner of Casas Bahia and Ponto Frio, may take longer than expected, since, even if the recession ends, the appliances must be one of the last to recover.
Health. With a focus on sectors considered resilient, Advent''s interest by the health segment has grown in recent years. In September 2015, bought 13% share of the Fleury diagnostic laboratory for about 400 million R$. In December of the same year, the Biotoscana laboratory, managed by the Fund, acquired argentina LKM. The Fund''s objective is to strengthen your presence in health in Latin America. "The purchase of the German lab, focusing on generic, reinforces this thesis", noted a source to the article.
Negotiations between Advent and German have been firmer at the end of last year, but based on price. The active-that''s how Pfizer shareholders, with 40%, and the family, with 60% – to have your market value estimated at 1.5 billion R$.
However, according to sources involved in the negotiations, it is expected that the operation is closed by a lower value. The contract could still contain future business performance goals. "There was an expectation that Pfizer exercise your right of first refusal to buy the remaining 60% of the company. However, a change in the overall strategy of Pfizer, which can leave the generic segment, did the company review this position, "said another source. Sought, Pfizer and Teutonic have yet to comment.
Other thread considered the Fund''s priority of education. The purchase of the Cesuca College, at the end of 2016, two years after getting out of Kroton – which is in the process of merging with Estácio – demonstrates that the manager returned to have appetite in this sector, despite the reduction in the budget for the student government funding program, Fies.
Within the process of Union of Statius and Kroton, the Advent intends to look at the assets to be sold by to obtain the approval of the Administrative Council for economic Defense (Cade) to merge.
Logistics. While active in Brazil and analyzes in Latin America – the Advent raised $2.1 billion at the end of 2014, to invest in the region – the Manager will be able to raise new cash by selling your slice of 50% of TCP port terminal. The Advent paid $1 billion for 50% of terminal in 2011. The original plan, according to sources, was open TCP''s capital, but the interest of investors for the active Manager to put the business up for sale.
Among those quoted to stay with the business are Dubai Ports World, China Merchants and APM Terminals, with headquarters in the Netherlands, which is already a shareholder of TCP. Sought, the Advent doesn''t comment. The other companies did not return requests for interviews.